As a long term holder, with a long term view on this, I am super excited to read the part regarding non-dilutive funding! It is wonderful to see this in writing, confirming the companies self belief in it's ability to see this through to market!
Further- from the standpoint of my professional interest (Master of Neurological Rehabilitation), this is definitely an exciting collaboration. The Walter Reed Army Institute of Research are a highly reputable research organisation. This can only be viewed as excellent news and will open many many doors as this drug progresses through trials, toward market.
Unlike many others, I bought into Nyrada for it's research on neuroprotective drugs, not the Cholesterol drugs. Seems that both are getting set to fly, averaged up on this mornings pull back shortly after the ANN. Win Win!
Long term holders will be rewarded here, IMO. Good luck to all!
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)